Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	serine-type endopeptidase inhibitor activity	HRG ANOS1 SPINT1	4.67e-04	105	29	3	GO:0004867
GeneOntologyMolecularFunction	histone demethylase activity	RSBN1 JMJD1C	9.23e-04	31	29	2	GO:0032452
GeneOntologyMolecularFunction	protein demethylase activity	RSBN1 JMJD1C	9.83e-04	32	29	2	GO:0140457
GeneOntologyCellularComponent	bBAF complex	SMARCC2 ARID1B	7.73e-05	10	28	2	GO:0140092
GeneOntologyCellularComponent	npBAF complex	SMARCC2 ARID1B	1.56e-04	14	28	2	GO:0071564
GeneOntologyCellularComponent	brahma complex	SMARCC2 ARID1B	1.56e-04	14	28	2	GO:0035060
GeneOntologyCellularComponent	nBAF complex	SMARCC2 ARID1B	2.05e-04	16	28	2	GO:0071565
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	SMARCC2 ARID1B YY1	2.83e-04	96	28	3	GO:0070603
GeneOntologyCellularComponent	ATPase complex	SMARCC2 ARID1B YY1	6.72e-04	129	28	3	GO:1904949
GeneOntologyCellularComponent	SWI/SNF complex	SMARCC2 ARID1B	7.35e-04	30	28	2	GO:0016514
GeneOntologyCellularComponent	nuclear matrix	SMARCC2 NCOR2 YY1	8.52e-04	140	28	3	GO:0016363
GeneOntologyCellularComponent	postsynaptic density membrane	SLITRK5 SHISA7 PRR7	1.19e-03	157	28	3	GO:0098839
GeneOntologyCellularComponent	nuclear periphery	SMARCC2 NCOR2 YY1	1.52e-03	171	28	3	GO:0034399
GeneOntologyCellularComponent	postsynaptic specialization membrane	SLITRK5 SHISA7 PRR7	2.40e-03	201	28	3	GO:0099634
GeneOntologyCellularComponent	chromatin	HOXA9 SMARCC2 NCOR2 POU3F2 ARID1B YY1 JMJD1C	2.78e-03	1480	28	7	GO:0000785
GeneOntologyCellularComponent	postsynaptic density	SLITRK5 SHISA7 PRR7 CPEB4	2.90e-03	451	28	4	GO:0014069
GeneOntologyCellularComponent	asymmetric synapse	SLITRK5 SHISA7 PRR7 CPEB4	3.55e-03	477	28	4	GO:0032279
GeneOntologyCellularComponent	postsynaptic specialization	SLITRK5 SHISA7 PRR7 CPEB4	4.29e-03	503	28	4	GO:0099572
GeneOntologyCellularComponent	neuron to neuron synapse	SLITRK5 SHISA7 PRR7 CPEB4	4.92e-03	523	28	4	GO:0098984
GeneOntologyCellularComponent	histone deacetylase complex	NCOR2 JMJD1C	5.77e-03	85	28	2	GO:0000118
GeneOntologyCellularComponent	transcription regulator complex	HOXA9 NCOR2 POU3F2 YY1	7.78e-03	596	28	4	GO:0005667
HumanPheno	Broad philtrum	SMARCC2 ARID1B PIGO	3.50e-05	45	8	3	HP:0000289
HumanPheno	Hypoplastic fingernail	SMARCC2 ARID1B PIGO	5.74e-05	53	8	3	HP:0001804
HumanPheno	Broad nasal tip	SMARCC2 ARID1B YY1 PIGO	5.80e-05	159	8	4	HP:0000455
HumanPheno	Intellectual disability, moderate	SMARCC2 ARID1B YY1 PIGO	7.90e-05	172	8	4	HP:0002342
HumanPheno	Abnormal nasal tip morphology	SMARCC2 ARID1B YY1 JMJD1C PIGO	1.13e-04	386	8	5	HP:0000436
HumanPheno	Craniosynostosis	GLIS3 YY1 JMJD1C PIGO	1.17e-04	190	8	4	HP:0001363
HumanPheno	Hypoplastic fifth fingernail	SMARCC2 ARID1B	1.95e-04	14	8	2	HP:0008398
HumanPheno	Aplastic/hypoplastic fingernail	SMARCC2 ARID1B PIGO	2.12e-04	82	8	3	HP:0008384
HumanPheno	Abnormality of upper lip vermillion	GLIS3 SMARCC2 ARID1B YY1 PIGO	2.73e-04	464	8	5	HP:0011339
HumanPheno	Prominent eyelashes	SMARCC2 ARID1B	2.90e-04	17	8	2	HP:0011231
HumanPheno	Oral aversion	SMARCC2 ARID1B	2.90e-04	17	8	2	HP:0012523
HumanPheno	Abnormal renal morphology	GLIS3 SMARCC2 ANOS1 ARID1B YY1 JMJD1C PIGO	3.36e-04	1252	8	7	HP:0012210
HumanPheno	Hypoplastic fifth toenail	SMARCC2 ARID1B	3.64e-04	19	8	2	HP:0011937
HumanPheno	Abnormal patella morphology	ARID1B YY1 JMJD1C	4.94e-04	109	8	3	HP:0003045
HumanPheno	Atrial septal defect	SMARCC2 ARID1B YY1 JMJD1C PIGO	5.65e-04	541	8	5	HP:0001631
HumanPheno	Abnormality of the atrial septum	SMARCC2 ARID1B YY1 JMJD1C PIGO	5.65e-04	541	8	5	HP:0001630
HumanPheno	Abnormal atrial septum morphology	SMARCC2 ARID1B YY1 JMJD1C PIGO	5.80e-04	544	8	5	HP:0011994
HumanPheno	Papillary thyroid carcinoma	SMARCC2 ARID1B	5.86e-04	24	8	2	HP:0002895
HumanPheno	Abnormality of the thyroid gland	GLIS3 SMARCC2 ARID1B YY1 JMJD1C	6.01e-04	548	8	5	HP:0000820
HumanPheno	Choanal atresia	GLIS3 ARID1B JMJD1C	7.04e-04	123	8	3	HP:0000453
HumanPheno	Abnormal eating behavior	SMARCC2 ARID1B YY1	7.91e-04	128	8	3	HP:0100738
HumanPheno	Wide nasal base	SMARCC2 ARID1B	7.99e-04	28	8	2	HP:0012810
HumanPheno	Hepatoblastoma	SMARCC2 ARID1B	7.99e-04	28	8	2	HP:0002884
HumanPheno	Abnormality of the pharynx	SMARCC2 ARID1B YY1 JMJD1C	8.74e-04	320	8	4	HP:0000600
HumanPheno	Feeding difficulties in infancy	SMARCC2 ARID1B YY1 JMJD1C PIGO	8.78e-04	594	8	5	HP:0008872
HumanPheno	Choanal atresia or stenosis	GLIS3 ARID1B JMJD1C	9.05e-04	134	8	3	HP:0000416
HumanPheno	Abnormal choanae morphology	GLIS3 ARID1B JMJD1C	9.05e-04	134	8	3	HP:0000415
HumanPheno	Abnormal nasal base norphology	SMARCC2 ARID1B	9.19e-04	30	8	2	HP:0012808
HumanPheno	Thick lower lip vermilion	SMARCC2 ARID1B YY1	9.45e-04	136	8	3	HP:0000179
HumanPheno	Abnormal upper lip morphology	GLIS3 SMARCC2 ARID1B YY1 JMJD1C PIGO	9.80e-04	980	8	6	HP:0000177
HumanPheno	Abnormal cardiac atrium morphology	SMARCC2 ARID1B YY1 JMJD1C PIGO	1.05e-03	617	8	5	HP:0005120
HumanPheno	Prenatal growth deficiency	GLIS3 SMARCC2 ARID1B YY1 JMJD1C	1.17e-03	631	8	5	HP:0001515
HumanPheno	Intrauterine growth retardation	GLIS3 SMARCC2 ARID1B YY1 JMJD1C	1.17e-03	631	8	5	HP:0001511
HumanPheno	Neoplasm of the endocrine system	SMARCC2 ARID1B YY1	1.38e-03	155	8	3	HP:0100568
HumanPheno	Prominent lips	SMARCC2 ARID1B YY1	1.41e-03	156	8	3	HP:0000184
HumanPheno	Intellectual disability, mild	GLIS3 ARID1B YY1 JMJD1C	1.44e-03	365	8	4	HP:0001256
HumanPheno	Intellectual disability, severe	SMARCC2 ARID1B YY1 PIGO	1.53e-03	371	8	4	HP:0010864
HumanPheno	Thick nasal alae	SMARCC2 ARID1B	1.55e-03	39	8	2	HP:0009928
HumanPheno	Autistic behavior	SMARCC2 ARID1B YY1 JMJD1C PIGO	1.63e-03	678	8	5	HP:0000729
HumanPheno	Abnormality of the ureter	ARID1B YY1 JMJD1C PIGO	1.73e-03	383	8	4	HP:0000069
HumanPheno	Abnormality of cranial sutures	GLIS3 YY1 JMJD1C PIGO	1.81e-03	388	8	4	HP:0011329
Domain	SANT_dom	SMARCC2 NCOR2	7.39e-04	26	29	2	IPR017884
Domain	SANT	SMARCC2 NCOR2	8.58e-04	28	29	2	PS51293
Domain	-	HOXA9 SMARCC2 NCOR2 POU3F2	9.09e-04	283	29	4	1.10.10.60
Domain	Myb_DNA-binding	SMARCC2 NCOR2	1.34e-03	35	29	2	PF00249
Domain	MYB_LIKE	SMARCC2 NCOR2	1.58e-03	38	29	2	PS50090
Domain	Homeodomain-like	HOXA9 SMARCC2 NCOR2 POU3F2	1.64e-03	332	29	4	IPR009057
Domain	SANT	SMARCC2 NCOR2	2.72e-03	50	29	2	SM00717
Domain	SANT/Myb	SMARCC2 NCOR2	2.94e-03	52	29	2	IPR001005
Pathway	REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION	SMARCC2 POU3F2 ARID1B	3.61e-04	95	21	3	M48268
Pathway	KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION	HOXA9 JMJD1C	6.72e-04	26	21	2	M47439
Pathway	WP_KLEEFSTRA_SYNDROME	SMARCC2 ARID1B	8.38e-04	29	21	2	M48076
Pathway	REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY	NCOR2 RNF111	9.58e-04	31	21	2	M669
Pathway	WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1	SMARCC2 ARID1B	9.58e-04	31	21	2	M39522
Pathway	REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT	SMARCC2 POU3F2 ARID1B	1.05e-03	137	21	3	M48232
Pathway	KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY	SMARCC2 ARID1B	1.22e-03	35	21	2	M47969
Pathway	REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN	SMARCC2 ARID1B	1.36e-03	37	21	2	M27797
Pathway	REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER	NCOR2 RNF111	1.67e-03	41	21	2	MM14876
Pathway	REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION	SMARCC2 ARID1B	1.76e-03	42	21	2	M48237
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	CD44 HOXA9 SMARCC2 RSBN1 FNDC3B NCOR2 ARID1B CHERP YY1 PHF3 JMJD1C RNF111	8.37e-11	1203	29	12	29180619
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	SMARCC2 NCOR2 ARID1B JMJD1C	5.33e-07	78	29	4	28611094
Pubmed	Loss of BAF Complex in Developing Cortex Perturbs Radial Neuronal Migration in a WNT Signaling-Dependent Manner.	SMARCC2 POU3F2 ARID1B	5.89e-07	20	29	3	34220450
Pubmed	JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis.	HOXA9 JMJD1C	6.71e-07	2	29	2	30622285
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	SMARCC2 RSBN1 NCOR2 ARID1B CHERP YY1 PHF3 JMJD1C	8.01e-07	954	29	8	36373674
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	CD44 SMARCC2 RSBN1 FNDC3B NCOR2 CHERP YY1 PIGO CPEB4	1.75e-06	1451	29	9	30550785
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	SMARCC2 ARID1B CHERP PHF3 JMJD1C	2.67e-06	268	29	5	33640491
Pubmed	EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation.	SMARCC2 ARID1B CHERP YY1	3.87e-06	128	29	4	23858473
Pubmed	Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1.	SMARCC2 NCOR2 ARID1B	5.04e-06	40	29	3	34585037
Pubmed	Regulation of the CUL3 Ubiquitin Ligase by a Calcium-Dependent Co-adaptor.	SMARCC2 ARID1B CHERP	9.95e-06	50	29	3	27716508
Pubmed	The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest.	SMARCC2 ARID1B	1.00e-05	6	29	2	16230384
Pubmed	Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats.	ARID1B CHERP	1.00e-05	6	29	2	8896557
Pubmed	Gene-environment interaction in the etiology of mathematical ability using SNP sets.	ARID1B NUAK1	1.41e-05	7	29	2	20978832
Pubmed	Target genes of the largest human SWI/SNF complex subunit control cell growth.	SMARCC2 ARID1B	1.41e-05	7	29	2	21118156
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	SLITRK5 NCOR2 CHERP JMJD1C	1.49e-05	180	29	4	35198878
Pubmed	The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.	SMARCC2 HRG NCOR2 ARID1B CHERP	1.77e-05	396	29	5	26687479
Pubmed	Loss of BAF (mSWI/SNF) Complexes Causes Global Transcriptional and Chromatin State Changes in Forebrain Development.	SMARCC2 POU3F2 ARID1B	2.20e-05	65	29	3	26655900
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	SMARCC2 NCOR2 PHF3 JMJD1C	2.39e-05	203	29	4	22083510
Pubmed	Coffin-Siris Syndrome	SMARCC2 ARID1B	2.41e-05	9	29	2	23556151
Pubmed	Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B.	SMARCC2 ARID1B	2.41e-05	9	29	2	20086098
Pubmed	The BAF chromatin complex component SMARCC1 does not mediate GLI transcriptional repression of Hedgehog target genes in limb buds.	SMARCC2 ARID1B	2.41e-05	9	29	2	37805104
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ARID1B FAM193A CHERP YY1 PHF3 JMJD1C	2.70e-05	733	29	6	34672954
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	HOXA9 SMARCC2 RSBN1 NCOR2 ARID1B YY1 CPEB4	2.89e-05	1116	29	7	31753913
Pubmed	Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway.	SMARCC2 ARID1B	3.01e-05	10	29	2	16751102
Pubmed	Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner.	SMARCC2 ARID1B	3.01e-05	10	29	2	12665591
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	GLIS3 FNDC3B NCOR2 ARID1B JMJD1C	3.51e-05	457	29	5	32344865
Pubmed	SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones.	SMARCC2 ARID1B	4.41e-05	12	29	2	11734557
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOR2 ARID1B JMJD1C	4.58e-05	83	29	3	28794006
Pubmed	Separation and Quantification of Some Alkaloids from Fumaria parviflora by Capillary Isotachophoresis1.	SMARCC2 ARID1B	5.21e-05	13	29	2	17340523
Pubmed	Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome.	SMARCC2 ARID1B	6.07e-05	14	29	2	36289231
Pubmed	APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.	ARID1B NUAK1	6.07e-05	14	29	2	23419831
Pubmed	Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation.	SMARCC2 ARID1B	7.00e-05	15	29	2	11175787
Pubmed	Kinetic analysis of npBAF to nBAF switching reveals exchange of SS18 with CREST and integration with neural developmental pathways.	SMARCC2 ARID1B	7.00e-05	15	29	2	23785148
Pubmed	Regulation of dendritic development by neuron-specific chromatin remodeling complexes.	SMARCC2 ARID1B	7.00e-05	15	29	2	17920018
Pubmed	The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression.	SMARCC2 ARID1B	7.00e-05	15	29	2	11263494
Pubmed	A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1.	SMARCC2 NCOR2	8.00e-05	16	29	2	11013263
Pubmed	Identification of a polymorphic, neuron-specific chromatin remodeling complex.	SMARCC2 ARID1B	9.06e-05	17	29	2	12368262
Pubmed	The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes.	SMARCC2 ARID1B	9.06e-05	17	29	2	11078522
Pubmed	Multiple enhancers regulate Hoxd genes and the Hotdog LncRNA during cecum budding.	CD44 HOXA9	9.06e-05	17	29	2	24075990
Pubmed	BAF complexes facilitate decatenation of DNA by topoisomerase IIα.	SMARCC2 ARID1B	1.02e-04	18	29	2	23698369
Pubmed	Generalist genes analysis of DNA markers associated with mathematical ability and disability reveals shared influence across ages and abilities.	ARID1B NUAK1	1.02e-04	18	29	2	20602751
Pubmed	Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions.	GLIS3 NCOR2 YY1	1.06e-04	110	29	3	37219487
Pubmed	The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.	CD44 NCOR2 YY1 JMJD1C	1.06e-04	298	29	4	30737378
Pubmed	SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care.	HRG SELENOP	1.14e-04	19	29	2	34099652
Pubmed	Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes.	SMARCC2 ARID1B	1.14e-04	19	29	2	12110891
Pubmed	Mammalian SWI/SNF complexes facilitate DNA double-strand break repair by promoting gamma-H2AX induction.	SMARCC2 ARID1B	1.14e-04	19	29	2	16932743
Pubmed	Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.	NCOR2 JMJD1C	1.40e-04	21	29	2	19596656
Pubmed	Pbx1/Pbx2 requirement for distal limb patterning is mediated by the hierarchical control of Hox gene spatial distribution and Shh expression.	CD44 HOXA9	1.68e-04	23	29	2	16672333
Pubmed	Diversity and specialization of mammalian SWI/SNF complexes.	SMARCC2 ARID1B	1.68e-04	23	29	2	8804307
Pubmed	FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex.	SMARCC2 ARID1B	1.68e-04	23	29	2	30962207
Pubmed	Role of β-catenin in development of bile ducts.	CD44 GLIS3	1.68e-04	23	29	2	26856660
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	SMARCC2 RSBN1 ARID1B JMJD1C	1.78e-04	341	29	4	32971831
Pubmed	BCOR modulates transcriptional activity of a subset of glucocorticoid receptor target genes involved in cell growth and mobility.	NCOR2 JMJD1C	1.83e-04	24	29	2	33722704
Pubmed	The SWI/SNF chromatin-remodeling factor stimulates repair by human excision nuclease in the mononucleosome core particle.	SMARCC2 ARID1B	1.83e-04	24	29	2	12215535
Pubmed	SWI/SNF chromatin remodeling and cancer.	SMARCC2 ARID1B	1.83e-04	24	29	2	11790558
Pubmed	Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits.	SMARCC2 ARID1B	1.83e-04	24	29	2	10078207
Pubmed	Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF.	SMARCC2 ARID1B	2.15e-04	26	29	2	10778858
Pubmed	Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.	SMARCC2 ARID1B	2.33e-04	27	29	2	29374058
Pubmed	NANOG-dependent function of TET1 and TET2 in establishment of pluripotency.	NCOR2 JMJD1C	2.33e-04	27	29	2	23395962
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	SMARCC2 RSBN1 YY1 PHF3	2.43e-04	370	29	4	22922362
Pubmed	Chromatin regulation by BAF170 controls cerebral cortical size and thickness.	SMARCC2 POU3F2	2.50e-04	28	29	2	23643363
Pubmed	Eda-activated RelB recruits an SWI/SNF (BAF) chromatin-remodeling complex and initiates gene transcription in skin appendage formation.	SMARCC2 ARID1B	2.50e-04	28	29	2	30037996
Pubmed	REST repression of neuronal genes requires components of the hSWI.SNF complex.	SMARCC2 ARID1B	2.50e-04	28	29	2	12192000
Pubmed	An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency.	SMARCC2 ARID1B	2.69e-04	29	29	2	19279220
Pubmed	RNF138 inhibits late inflammatory gene transcription through degradation of SMARCC1 of the SWI/SNF complex.	SMARCC2 ARID1B	2.69e-04	29	29	2	36800290
Pubmed	Mammalian SWI/SNF collaborates with a polycomb-associated protein to regulate male germline transcription in the mouse.	SMARCC2 ARID1B	2.88e-04	30	29	2	31043422
Pubmed	Control of developmentally primed erythroid genes by combinatorial co-repressor actions.	NCOR2 JMJD1C	2.88e-04	30	29	2	26593974
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	CD44 FNDC3B FAM193A PHF3 CPEB4	3.03e-04	724	29	5	36232890
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	SMARCC2 NCOR2 ARID1B JMJD1C	3.20e-04	398	29	4	35016035
Pubmed	Sf3b4 regulates chromatin remodeler splicing and Hox expression.	HOXA9 JMJD1C	3.28e-04	32	29	2	37167859
Pubmed	Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease.	HRG PRR7	3.49e-04	33	29	2	22703881
Pubmed	The PcG protein hPc2 interacts with the N-terminus of histone demethylase JARID1B and acts as a transcriptional co-repressor.	SMARCC2 ARID1B	3.49e-04	33	29	2	19336002
Pubmed	The core SWI/SNF catalytic subunit Brg1 regulates nephron progenitor cell proliferation and differentiation.	SMARCC2 ARID1B	3.93e-04	35	29	2	32504627
Pubmed	Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma.	FNDC3B CHERP	3.93e-04	35	29	2	30942445
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	GLIS3 NCOR2 FAM193A PRR7	4.28e-04	430	29	4	35044719
Pubmed	Analysis of the SWI/SNF chromatin-remodeling complex during early heart development and BAF250a repression cardiac gene transcription during P19 cell differentiation.	SMARCC2 ARID1B	4.39e-04	37	29	2	24335282
Pubmed	Chromatin Remodeling BAF155 Subunit Regulates the Genesis of Basal Progenitors in Developing Cortex.	SMARCC2 POU3F2	4.63e-04	38	29	2	30240734
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	NCOR2 FAM193A JMJD1C	4.81e-04	184	29	3	32908313
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	SMARCC2 ARID1B PHF3 JMJD1C	5.21e-04	453	29	4	29656893
Pubmed	Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.	SLITRK5 SHISA7 PRR7	5.87e-04	197	29	3	36604605
Pubmed	Protein interaction studies in human induced neurons indicate convergent biology underlying autism spectrum disorders.	SMARCC2 ARID1B	5.93e-04	43	29	2	36950384
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	CD44 RSBN1 ARID1B PHF3	6.08e-04	472	29	4	38943005
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	CDK20 SMARCC2 NCOR2 YY1 JMJD1C	6.52e-04	857	29	5	25609649
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	GLIS3 FNDC3B ARID1B JMJD1C	7.37e-04	497	29	4	23414517
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	FBXO41 ZC3H12C CPEB4	7.87e-04	218	29	3	33378226
Interaction	RNF4 interactions	CD44 HOXA9 SMARCC2 RSBN1 FNDC3B NCOR2 ARID1B CHERP YY1 PHF3 JMJD1C RNF111	2.26e-07	1412	29	12	int:RNF4
Interaction	SOX7 interactions	SMARCC2 NCOR2 ARID1B JMJD1C	5.60e-06	82	29	4	int:SOX7
Interaction	SMC5 interactions	SMARCC2 RSBN1 NCOR2 ARID1B CHERP YY1 PHF3 JMJD1C	6.03e-05	1000	29	8	int:SMC5
Interaction	CFD interactions	CD44 SMARCC2 RSBN1 FNDC3B NCOR2 CHERP YY1 PIGO CPEB4	8.23e-05	1360	29	9	int:CFD
Interaction	SMG7 interactions	NCOR2 ARID1B FAM193A JMJD1C CPEB4	8.37e-05	319	29	5	int:SMG7
Interaction	CNOT2 interactions	NCOR2 FAM193A JMJD1C CPEB4	1.18e-04	178	29	4	int:CNOT2
Interaction	GCM1 interactions	SMARCC2 NCOR2 ARID1B	1.26e-04	68	29	3	int:GCM1
Interaction	ALG13 interactions	NCOR2 ARID1B JMJD1C CPEB4	1.31e-04	183	29	4	int:ALG13
Interaction	LHX2 interactions	SMARCC2 NCOR2 ARID1B YY1	1.31e-04	183	29	4	int:LHX2
Interaction	FNDC5 interactions	CD44 SMARCC2 RSBN1 FNDC3B NCOR2 CHERP YY1 PIGO CPEB4	1.50e-04	1470	29	9	int:FNDC5
Interaction	POU5F1 interactions	SMARCC2 HRG NCOR2 ARID1B PHF3 JMJD1C	1.55e-04	584	29	6	int:POU5F1
Interaction	PAX6 interactions	SMARCC2 NCOR2 ARID1B YY1 RNF111	1.59e-04	366	29	5	int:PAX6
Interaction	CREBBP interactions	HOXA9 SMARCC2 NCOR2 ARID1B YY1 RNF111	1.78e-04	599	29	6	int:CREBBP
Interaction	TLE3 interactions	SMARCC2 NCOR2 ARID1B FAM193A CHERP	1.81e-04	376	29	5	int:TLE3
Interaction	SMAD2 interactions	HOXA9 SMARCC2 ARID1B YY1 RNF111	2.02e-04	385	29	5	int:SMAD2
Interaction	QPRT interactions	NCOR2 ARID1B JMJD1C	2.36e-04	84	29	3	int:QPRT
Interaction	SNRNP40 interactions	SMARCC2 RSBN1 NCOR2 ARID1B CHERP YY1	2.49e-04	637	29	6	int:SNRNP40
Interaction	ERG interactions	SMARCC2 NCOR2 ARID1B RNF111	2.79e-04	223	29	4	int:ERG
Interaction	NFIX interactions	SMARCC2 NCOR2 ARID1B YY1	2.98e-04	227	29	4	int:NFIX
Interaction	SOX10 interactions	NCOR2 POU3F2 ARID1B	3.09e-04	92	29	3	int:SOX10
Interaction	NUP35 interactions	GLIS3 FNDC3B NCOR2 ARID1B JMJD1C	3.15e-04	424	29	5	int:NUP35
Interaction	BCL7B interactions	SMARCC2 RSBN1 ARID1B	3.39e-04	95	29	3	int:BCL7B
Interaction	TEX13B interactions	SMARCC2 ARID1B	3.74e-04	20	29	2	int:TEX13B
Interaction	ASF1A interactions	SMARCC2 NCOR2 ARID1B PHF3	4.24e-04	249	29	4	int:ASF1A
Interaction	H2BC4 interactions	SMARCC2 YY1 PHF3 JMJD1C	4.92e-04	259	29	4	int:H2BC4
Interaction	PRMT5 interactions	GLIS3 HOXA9 SMARCC2 NCOR2 ARID1B	5.10e-04	471	29	5	int:PRMT5
Interaction	NANOG interactions	HRG NCOR2 ARID1B CHERP JMJD1C	5.61e-04	481	29	5	int:NANOG
Interaction	TBXT interactions	SMARCC2 NCOR2 ARID1B	6.09e-04	116	29	3	int:TBXT
Interaction	HNF4A interactions	SMARCC2 NCOR2 ARID1B YY1	6.16e-04	275	29	4	int:HNF4A
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	SMARCC2 NCOR2	1.88e-03	53	22	2	532
GeneFamily	Fibronectin type III domain containing	FNDC3B ANOS1	1.60e-02	160	22	2	555
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	GLIS3 FNDC3B ARID1B JMJD1C	7.02e-06	192	29	4	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	LA-14._Fibroblast_III\|LA / Chamber and Cluster_Paper	CD44 GLIS3 NCOR2 ARID1B	7.17e-06	193	29	4	7426c291bac59e539c427bcaae18abc7d397d44e
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FNDC3B ARID1B JMJD1C RNF111	7.17e-06	193	29	4	779276e775cb2492e8dd36436295a536084a6415
ToppCell	LA-14._Fibroblast_III\|World / Chamber and Cluster_Paper	CD44 GLIS3 NCOR2 ARID1B	7.32e-06	194	29	4	803fa83ceada17c38ca9f933b888f7e7b0b90761
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon\|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type.	CD44 GLIS3 POU3F2 SELENOP	7.77e-06	197	29	4	58b957efd006f43c2fe55071d5c6d06c2e367e72
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	SLITRK5 ARID1B JMJD1C	1.17e-04	147	29	3	94998bc40f5c08295cfe3bdcbe43f13b1e564b3d
ToppCell	severe_influenza-cDC\|World / disease group, cell group and cell class (v2)	HOXA9 SELENOP SPINT1	1.53e-04	161	29	3	802f8cafb5f499e3b2ec0193d6eb1ac9320b9287
ToppCell	facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HRG FNDC3B ZC3H12C	1.83e-04	171	29	3	6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794
ToppCell	facs-Marrow-T-cells-3m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HRG FNDC3B ZC3H12C	1.83e-04	171	29	3	e02b5831768dbb1b68998b672e55c9680ab0cc86
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CD44 GLIS3 FNDC3B	1.86e-04	172	29	3	0c2d0bb767e5ce089b42ad49e8b303a103de2d5c
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD44 GLIS3 SHISA7	1.86e-04	172	29	3	3f784aed340b50ddbec3f7dc0a5279180d38a2bb
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CD44 GLIS3 FNDC3B	1.86e-04	172	29	3	eeed177a03c116e9815a8e086d24efc9643b16a4
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-B_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD44 ZC3H12C PHF3	1.90e-04	173	29	3	0a0cd40bb5f61431fe34758626c8a63ec610a8a5
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SLITRK5 ANOS1 SPINT1	2.03e-04	177	29	3	8c6d8a1c469346e66f9095d86b4615f8fc611362
ToppCell	Children_(3_yrs)-Epithelial-basal_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SLITRK5 GLIS3 ANOS1	2.06e-04	178	29	3	fba2e38c05cbf031e0c6d47b1602575fea734a57
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SLITRK5 GLIS3 ANOS1	2.24e-04	183	29	3	ec2af3402b51f11466d2a5783a6b33746b6a7fc9
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC3B NCOR2 NUAK1	2.24e-04	183	29	3	83592c332b1e82673f993d37c7f480befdc3dcda
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	NCOR2 ANOS1 SPINT1	2.27e-04	184	29	3	bde4eaabd3e9bdaed23867d23a919b9d84b52d4b
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)\|343B / Donor, Lineage, Cell class and subclass (all cells)	NCOR2 ANOS1 SPINT1	2.27e-04	184	29	3	cb15d6bae52c5ec251c2235859dc7e65f630ae23
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CD44 GLIS3 FNDC3B	2.46e-04	189	29	3	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	RA-14._Fibroblast_III\|RA / Chamber and Cluster_Paper	CD44 GLIS3 NCOR2	2.46e-04	189	29	3	46e9a58aacd79db5a02898a8c7244e1884adcfd1
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CD44 GLIS3 FNDC3B	2.46e-04	189	29	3	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-oRG/Astrocyte-7\|World / Primary Cells by Cluster	CD44 SELENOP ANOS1	2.50e-04	190	29	3	8f1c490dd8e5f80382f5294fd1aa8cba4c3c647f
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-oRG/Astrocyte\|World / Primary Cells by Cluster	CD44 SELENOP ANOS1	2.50e-04	190	29	3	7dbfd543398c63cbe1e68b54bcb5e2291f521935
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-RGCs_early_2\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	CD44 GLIS3 SELENOP	2.54e-04	191	29	3	06107849463a1ccb78a5ccd3ae31619ef6bedda3
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CD44 GLIS3 FNDC3B	2.54e-04	191	29	3	9032aa974aa1b7b1095b8d1b58dcb087358a5001
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CD44 FNDC3B ZC3H12C	2.54e-04	191	29	3	0b296404ebad0aadb75737f8c0462ec6934fc8bb
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CD44 GLIS3 FNDC3B	2.54e-04	191	29	3	5717809a1476c20f65bce722c5a57cff92ee0d7a
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-oRG-34\|World / Primary Cells by Cluster	CD44 SELENOP ANOS1	2.62e-04	193	29	3	d55f792eb3db10452347681131e07e041348fd89
ToppCell	Non-neuronal-Non-dividing-Radial_Glia\|World / Primary Cells by Cluster	CD44 SELENOP ANOS1	2.66e-04	194	29	3	1445b7611c2b1ab9b320f330d17d70117892cc28
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SLITRK5 GLIS3 SELENOP	2.66e-04	194	29	3	99577a5a631e607b5abe7a1b0d8d6a5eabe50196
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SLITRK5 GLIS3 SELENOP	2.70e-04	195	29	3	70387a62f121f8c374dba1aca9ab65cfed6a0b10
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD44 FNDC3B JMJD1C	2.74e-04	196	29	3	d9b5eaca4089d5337f1175a663418c9c675cdd87
ToppCell	COPD-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	CD44 RSBN1 JMJD1C	2.74e-04	196	29	3	c9bdd505c3ab380ed7b272aa518df31a0a706a06
ToppCell	control-Myeloid-Non-resident_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CD44 FNDC3B JMJD1C	2.78e-04	197	29	3	df2fe36cb96e2565a9d21c24cb4e451e8befd4be
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	ARID1B PHF3 JMJD1C	2.78e-04	197	29	3	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	3'-GW_trimst-1-LargeIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HOXA9 SELENOP SPINT1	2.78e-04	197	29	3	5027787ab3ce60e1ddcb99e3a01f40bb07b05804
ToppCell	15-Distal-Epithelial\|Distal / Age, Tissue, Lineage and Cell class	CD44 ANOS1 SPINT1	2.78e-04	197	29	3	9fbd1abf050b364155a67962a9731118304f72fb
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD44 FNDC3B JMJD1C	2.78e-04	197	29	3	037f5f26fa66818baa35846aa96336155e8a6f45
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-G\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	CD44 SELENOP NUAK1	2.78e-04	197	29	3	a21a710c824f9e5c7ef1674168d1ce5aef85bd35
ToppCell	Brain_organoid-organoid_Velasco_nature-6_mon-Macroglial-Astroglia\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	CD44 GLIS3 ANOS1	2.82e-04	198	29	3	715ecad21f572b195ff3b78216b1a7b32bbb4ace
ToppCell	Brain_organoid-organoid_Velasco_nature-6_mon-Macroglial\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	CD44 GLIS3 ANOS1	2.82e-04	198	29	3	9d03768f8b6c74e060c5f045508538f9b331f469
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	ARID1B PHF3 JMJD1C	2.82e-04	198	29	3	44417089b62056269cac38d3134ff209c05b7007
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ARID1B PHF3 JMJD1C	2.82e-04	198	29	3	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	distal-Epithelial-Basal-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SLITRK5 ANOS1 SPINT1	2.82e-04	198	29	3	dda0bf3a48f738df590ce23b891d82be19e10d66
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD44 FNDC3B JMJD1C	2.82e-04	198	29	3	ecd93e28bae4152467f6d6621cffc73c301c9795
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	GLIS3 YY1 CPEB4	2.86e-04	199	29	3	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	COPD-Myeloid-Macrophage\|Myeloid / Disease state, Lineage and Cell class	CD44 SELENOP ZC3H12C	2.86e-04	199	29	3	1cf1b2d6debf9e3389f1829dcaa2857e9533a080
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD44 FNDC3B JMJD1C	2.86e-04	199	29	3	9da8b48ec1c1c105fcbab6ae8f08166e7d5e8a35
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SLITRK5 SELENOP NUAK1	2.86e-04	199	29	3	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	GLIS3 YY1 PHF3	2.86e-04	199	29	3	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SLITRK5 ANOS1 SPINT1	2.86e-04	199	29	3	995d710d7302272e7951a5a5d766d1039089ee2b
ToppCell	343B-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	CD44 SELENOP NUAK1	2.86e-04	199	29	3	212e89d097753790061310373a1fafba773488b6
ToppCell	BAL-Severe-cDC_0\|Severe / Compartment, Disease Groups and Clusters	CD44 SELENOP ANOS1	2.86e-04	199	29	3	d39be8b173156bf87baddd3caed4b35597c53ea1
ToppCell	PSB-critical-LOC-Epithelial-Basal\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CD44 SELENOP ANOS1	2.86e-04	199	29	3	2add64c3e4cb6384ec381f34c3f1f77e13e3f27c
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal-Basal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SLITRK5 ANOS1 SPINT1	2.86e-04	199	29	3	e9c47f565a0a7737ecff68569d668aeb707ae5a6
ToppCell	343B-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	CD44 SELENOP NUAK1	2.86e-04	199	29	3	14b676aa289c0578a37be32cec3ea285c79d97cc
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related-Oligodendrocyte/OPC\|10w / Sample Type, Dataset, Time_group, and Cell type.	GLIS3 POU3F2 ZC3H12C	2.90e-04	200	29	3	345f1eac498cc87fd7bf08e7312608b2d6fe1dd7
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related\|10w / Sample Type, Dataset, Time_group, and Cell type.	GLIS3 POU3F2 ZC3H12C	2.90e-04	200	29	3	8f5d98f962ddd8c4658c89ff8a2894de1228562a
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ARID1B PHF3 JMJD1C	2.90e-04	200	29	3	12f1685ce8f218433068e090c9d839cd5a1910bf
Drug	Asbestos, Crocidolite	CD44 GLIS3 SMARCC2 SELENOP ARID1B ZC3H12C CHERP JMJD1C CPEB4	1.53e-05	1241	29	9	ctd:D017638
Drug	HMBA	CD44 HOXA9 POU3F2 YY1	4.52e-05	157	29	4	CID000003616
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	RSBN1 PHF3 JMJD1C RNF111	7.69e-05	180	29	4	4541_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	RSBN1 PHF3 JMJD1C RNF111	8.37e-05	184	29	4	2321_DN
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A	CD44 SMARCC2 YY1 PIGO	9.29e-05	189	29	4	5208_DN
Drug	prochlorperazine dimaleate salt; Down 200; 10uM; HL60; HT_HG-U133A	SLITRK5 HOXA9 SPINT1 PIGO	1.01e-04	193	29	4	2675_DN
Drug	Fusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A	CDK20 HOXA9 SMARCC2 PHF3	1.03e-04	194	29	4	3245_UP
Drug	Loracarbef [121961-22-6]; Up 200; 10.8uM; HL60; HT_HG-U133A	CDK20 FBXO41 PHF3 PRR7	1.05e-04	195	29	4	2970_UP
Drug	aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A	CDK20 CD44 YY1 PIGO	1.09e-04	197	29	4	5201_DN
Drug	Calciferol [50-14-6]; Up 200; 10uM; MCF7; HT_HG-U133A	CDK20 FBXO41 HOXA9 NCOR2	1.09e-04	197	29	4	3304_UP
Drug	Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; MCF7; HT_HG-U133A	CDK20 FBXO41 YY1 PIGO	1.09e-04	197	29	4	2265_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; HL60; HT_HG-U133A	CDK20 FBXO41 HOXA9 YY1	1.11e-04	198	29	4	2560_DN
Drug	Netilmicin sulfate [56931-57-2]; Up 200; 2.8uM; PC3; HT_HG-U133A	CDK20 FBXO41 NCOR2 PRR7	1.11e-04	198	29	4	7302_UP
Drug	Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A	SLITRK5 NCOR2 ANOS1 YY1	1.11e-04	198	29	4	3707_DN
Drug	Isoxicam [34552-84-6]; Down 200; 12uM; HL60; HT_HG-U133A	SLITRK5 HOXA9 YY1 PRR7	1.11e-04	198	29	4	1862_DN
Drug	nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A	SLITRK5 NCOR2 PIGO PRR7	1.13e-04	199	29	4	2683_DN
Drug	Methocarbamol [532-03-6]; Up 200; 16.6uM; MCF7; HT_HG-U133A	CDK20 CD44 YY1 PIGO	1.13e-04	199	29	4	7467_UP
Drug	Ribavirin [36791-04-5]; Down 200; 16.4uM; MCF7; HT_HG-U133A	CDK20 FBXO41 NUAK1 PHF3	1.16e-04	200	29	4	6521_DN
Drug	Todralazine hydrochloride [3778-76-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A	CD44 SMARCC2 YY1 PHF3	1.16e-04	200	29	4	5512_DN
Disease	fetuin-B measurement	HRG JMJD1C	3.89e-05	10	28	2	EFO_0008128
Disease	gastrin-releasing peptide measurement	HRG JMJD1C	4.75e-05	11	28	2	EFO_0022000
Disease	Coffin-Siris syndrome	SMARCC2 ARID1B	6.73e-05	13	28	2	C0265338
Disease	partial thromboplastin time	HRG SELENOP	2.37e-04	24	28	2	EFO_0004310
Disease	corpus callosum central volume measurement	NUAK1 PIGO	3.23e-04	28	28	2	EFO_0010296
Disease	cognitive function measurement, self reported educational attainment	POU3F2 ARID1B FAM193A JMJD1C	3.36e-04	355	28	4	EFO_0004784, EFO_0008354
Disease	attention deficit hyperactivity disorder, autism spectrum disorder, intelligence	POU3F2 ARID1B FAM193A JMJD1C	5.17e-04	398	28	4	EFO_0003756, EFO_0003888, EFO_0004337
Disease	alcohol use disorder (implicated_via_orthology)	SMARCC2 ARID1B JMJD1C	8.24e-04	195	28	3	DOID:1574 (implicated_via_orthology)
Disease	Acute Promyelocytic Leukemia	CD44 FNDC3B	8.76e-04	46	28	2	C0023487
Disease	FEV/FEC ratio	GLIS3 FNDC3B YY1 JMJD1C CPEB4 SKIDA1	8.79e-04	1228	28	6	EFO_0004713
Disease	total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement	ZC3H12C CPEB4	9.93e-04	49	28	2	EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612
Disease	monokine induced by gamma interferon measurement	RSBN1 FNDC3B	1.12e-03	52	28	2	EFO_0008236
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	NCOR2 JMJD1C RNF111	1.55e-03	243	28	3	EFO_0004612, EFO_0020944
Disease	very low density lipoprotein cholesterol measurement	NCOR2 JMJD1C RNF111	1.88e-03	260	28	3	EFO_0008317
Disease	serum albumin measurement	CD44 JMJD1C CPEB4 SKIDA1	2.24e-03	592	28	4	EFO_0004535
Disease	juvenile idiopathic arthritis	RSBN1 JMJD1C	2.25e-03	74	28	2	EFO_0002609
Disease	Nerve Degeneration	CD44 SELENOP	2.82e-03	83	28	2	C0027746
Disease	liver fibrosis measurement	GLIS3 JMJD1C	3.02e-03	86	28	2	EFO_0010576
Disease	neuroimaging measurement	GLIS3 NUAK1 JMJD1C CPEB4 SKIDA1	3.03e-03	1069	28	5	EFO_0004346
Disease	cortical thickness	GLIS3 ARID1B NUAK1 JMJD1C CPEB4	3.61e-03	1113	28	5	EFO_0004840
Disease	phospholipid measurement, intermediate density lipoprotein measurement	JMJD1C RNF111	3.98e-03	99	28	2	EFO_0004639, EFO_0008595
Disease	tyrosine measurement	HRG JMJD1C	4.38e-03	104	28	2	EFO_0005058
Disease	gallstones	JMJD1C SKIDA1	4.71e-03	108	28	2	EFO_0004210
Disease	sleep duration	GLIS3 POU3F2 SKIDA1	4.78e-03	362	28	3	EFO_0005271
Disease	atrial fibrillation	NCOR2 JMJD1C CPEB4	5.12e-03	371	28	3	EFO_0000275

Protein segments in the cluster

Peptide	Gene	Start	Entry
PKAHPGPPHIHDFHV	CDK20	311	Q8IZL9
GEAPAAPPHQQHHHH	ARID1B	156	Q8NFD5
HPALHLYPHIHGHVP	FAM193A	446	P78312
HRSHLKHRHPHHYKP	ANOS1	661	P23352
PPERHSPHHLKEQHH	NCOR2	1336	Q9Y618
PPFKPHGSRDHHHPH	HRG	276	P04196
PHHAVHHPHLLPTVL	JMJD1C	786	Q15652
HHHHPYVHPQAPVAA	HOXA9	86	P31269
VHVHPLLHHGPAQPH	PRR7	96	Q8TB68
LLHHGPAQPHAHAHP	PRR7	101	Q8TB68
HHHPGHRMPHPGINE	CHERP	586	Q8IWX8
PEAHPPLIHHEHHEE	CD44	361	P16070
HHLPPYLTHHPHFIH	FNDC3B	121	Q53EP0
PYHAHAHLHHPELGP	GLIS3	306	Q8NEA6
AGPSPAAPHLLHHHH	FBXO41	96	Q8TF61
PVRFHPHLQPPHHHQ	CPEB4	21	Q17RY0
RHKHHHHRGPDGDPS	RSBN1	191	Q5VWQ0
FHLVNGFCPPPHHHH	SKIDA1	326	Q1XH10
HPPHHHRPQPHLGSF	SKIDA1	361	Q1XH10
RGLPPPSSLHAHHHH	SHISA7	466	A6NL88
PRKPHGVKRHHHKHN	NUAK1	36	O60285
PPHLVHHAANHHPGP	POU3F2	151	P20265
PAPPNLHGHHHHLPF	SMARCC2	1111	Q8TAQ2
LHGHHHHLPFAPGTL	SMARCC2	1116	Q8TAQ2
THPAPPGLHHHHKHK	SELENOP	236	P49908
LHPHLAHYHAPPRLH	RNF111	826	Q6ZNA4
HPHAHVHHRGPALPK	SLITRK5	726	O94991
QRKDFHGHHHHPPPT	SPINT1	491	O43278
HHHHHPPMIALQPLV	YY1	76	P25490
HAHPGCLKEPHHPAQ	PHF3	601	Q92576
HCGHKHGPHHPEMAK	PIGO	236	Q8TEQ8
SHEEPKFHHKPPLPH	ZC3H12C	691	Q9C0D7